2021 Q3 Form 10-Q Financial Statement

#000121390021057316 Filed on November 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.088M
YoY Change 81.71%
% of Gross Profit
Research & Development $6.391M
YoY Change 3.08%
% of Gross Profit
Depreciation & Amortization $337.0K
YoY Change -3.71%
% of Gross Profit
Operating Expenses $11.44M
YoY Change 30.9%
Operating Profit -$11.44M
YoY Change
Interest Expense $9.000K
YoY Change -96.4%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$11.43M
YoY Change 34.65%
Income Tax
% Of Pretax Income
Net Earnings -$11.43M
YoY Change 34.65%
Net Earnings / Revenue
Basic Earnings Per Share -$0.36
Diluted Earnings Per Share -$357.2K
COMMON SHARES
Basic Shares Outstanding 32.00M shares
Diluted Shares Outstanding 32.00M shares

Balance Sheet

Concept 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.67M
YoY Change 50.03%
Cash & Equivalents $14.61M
Short-Term Investments $46.06M
Other Short-Term Assets $2.155M
YoY Change -4.22%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $62.83M
YoY Change 47.17%
LONG-TERM ASSETS
Property, Plant & Equipment $1.749M
YoY Change -49.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $18.48M
YoY Change 52.37%
Other Assets $689.0K
YoY Change 1.32%
Total Long-Term Assets $20.92M
YoY Change 28.67%
TOTAL ASSETS
Total Short-Term Assets $62.83M
Total Long-Term Assets $20.92M
Total Assets $83.75M
YoY Change 42.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.723M
YoY Change 106.83%
Accrued Expenses $6.642M
YoY Change 45.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.37M
YoY Change 24.13%
LONG-TERM LIABILITIES
Long-Term Debt $23.44M
YoY Change
Other Long-Term Liabilities $1.031M
YoY Change -37.89%
Total Long-Term Liabilities $24.48M
YoY Change 1374.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.37M
Total Long-Term Liabilities $24.48M
Total Liabilities $34.84M
YoY Change 248.4%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $48.91M
YoY Change
Total Liabilities & Shareholders Equity $83.75M
YoY Change 42.06%

Cashflow Statement

Concept 2021 Q3
OPERATING ACTIVITIES
Net Income -$11.43M
YoY Change 34.65%
Depreciation, Depletion And Amortization $337.0K
YoY Change -3.71%
Cash From Operating Activities -$8.789M
YoY Change 43.14%
INVESTING ACTIVITIES
Capital Expenditures -$15.00K
YoY Change -118.75%
Acquisitions
YoY Change
Other Investing Activities -$7.225M
YoY Change -268.81%
Cash From Investing Activities -$7.240M
YoY Change -272.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -8.789M
Cash From Investing Activities -7.240M
Cash From Financing Activities
Net Change In Cash $0.00
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$8.789M
Capital Expenditures -$15.00K
Free Cash Flow -$8.774M
YoY Change 41.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Local Phone Number
LocalPhoneNumber
74-7108600
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
USD
CY2020Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
USD
CY2021Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
USD
CY2020Q3 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
USD

Files In Submission

Name View Source Status
0001213900-21-057316-index-headers.html Edgar Link pending
0001213900-21-057316-index.html Edgar Link pending
0001213900-21-057316.txt Edgar Link pending
0001213900-21-057316-xbrl.zip Edgar Link pending
f10q0921ex31-1_pluristem.htm Edgar Link pending
f10q0921ex31-2_pluristem.htm Edgar Link pending
f10q0921ex32-1_pluristem.htm Edgar Link pending
f10q0921ex32-2_pluristem.htm Edgar Link pending
f10q0921_pluristemtherap.htm Edgar Link pending
f10q0921_pluristemtherap_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
psti-20210930.xsd Edgar Link pending
psti-20210930_cal.xml Edgar Link unprocessable
psti-20210930_def.xml Edgar Link unprocessable
psti-20210930_lab.xml Edgar Link unprocessable
psti-20210930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending